|
NHLRC3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.884000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.204200E-02 |
| Normal-vs-Stage2 |
2.097600E-02 |
| Normal-vs-Stage3 |
7.786800E-01 |
| Normal-vs-Stage4 |
5.007000E-01 |
| Stage1-vs-Stage2 |
2.253600E-01 |
| Stage1-vs-Stage3 |
1.516020E-01 |
| Stage1-vs-Stage4 |
2.656400E-02 |
| Stage2-vs-Stage3 |
4.359800E-02 |
| Stage2-vs-Stage4 |
9.760000E-03 |
| Stage3-vs-Stage4 |
4.441600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.201200E-01 |
| Normal-vs-AfricanAmerican |
3.135800E-01 |
| Normal-vs-Asian |
6.842100E-02 |
| Caucasian-vs-AfricanAmerican |
8.250600E-01 |
| Caucasian-vs-Asian |
9.241700E-02 |
| AfricanAmerican-vs-Asian |
1.259410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.847780E-01 |
| Normal-vs-Female |
4.521700E-02 |
| Male-vs-Female |
4.489200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.543800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.232300E-02 |
| Normal-vs-Age(61-80Yrs) |
2.268600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.513000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.136400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.631200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.609000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.525600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.138000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.144400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.376400E-02 |
| Normal-vs-Grade 2 |
1.185530E-02 |
| Normal-vs-Grade 3 |
4.227600E-01 |
| Normal-vs-Grade 4 |
6.836800E-01 |
| Grade 1-vs-Grade 2 |
1.036560E-01 |
| Grade 1-vs-Grade 3 |
2.452100E-02 |
| Grade 1-vs-Grade 4 |
1.296240E-02 |
| Grade 2-vs-Grade 3 |
1.151200E-01 |
| Grade 2-vs-Grade 4 |
4.228300E-02 |
| Grade 3-vs-Grade 4 |
3.529200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.381300E-03 |
| Normal-vs-ccB subtype |
3.895400E-01 |
| ccA subtype-vs-ccB subtype |
9.612500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.885700E-02 |
| Normal-vs-N1 |
8.209000E-01 |
| N0-vs-N1 |
7.086000E-01 |
|
|
